Effect of oxygen limitations on monoclonal antibody production by immobilized hybridoma cells

Mark Riley, Fernando J. Muzzio, Sebastian C. Reyes

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The productivity of an immobilized cell biocatalyst is often limited by the amount of oxygen that reaches cells located at interior regions of the biocatalyst. These diffusive limitations depend on a multitude of factors including the oxygen supply, the cellular uptake kinetics, and the cell density of the material. Large cell densities, which are desired for high productivity, are also likely to reduce the percentage of cells that receive an adequate supply of oxygen. To develop a better understanding of how different conditions affect biocatalyst behavior, a computational model of immobilized hybridoma cells was developed. The model accounts for oxygen diffusion and consumption, cell proliferation and death, and monoclonal antibody production. This model assumes that cellular productivity is limited only by the supply of oxygen and that the growth media is continually replenished so that nutrient levels remain high and wastes are eliminated. Biocatalyst performance is evaluated by monitoring the amount of monoclonal antibody produced by the cells. Model predictions agree with experimental measurements reported in the literature and indicate that for long operation time the supply of oxygen, biocatalyst size, and cell kinetics have a significant effect on biocatalyst performance, whereas the initial cell loading has only a relatively small effect. Under typical culture conditions, we find that oxygen penetrates to a maximum depth of about 0.4 mm. Accordingly, cells immobilized farther than this threshold distance receive an insufficient supply of oxygen.

Original languageEnglish (US)
Pages (from-to)301-310
Number of pages10
JournalBiotechnology Progress
Volume13
Issue number3
DOIs
StatePublished - May 1 1997

Fingerprint

Immobilized Cells
Hybridomas
Antibody Formation
Monoclonal Antibodies
Oxygen
Enzymes
Cell Count
Cell Size
Oxygen Consumption
Cell Death
Cell Proliferation
Food
Growth

ASJC Scopus subject areas

  • Biotechnology

Cite this

Effect of oxygen limitations on monoclonal antibody production by immobilized hybridoma cells. / Riley, Mark; Muzzio, Fernando J.; Reyes, Sebastian C.

In: Biotechnology Progress, Vol. 13, No. 3, 01.05.1997, p. 301-310.

Research output: Contribution to journalArticle

Riley, Mark ; Muzzio, Fernando J. ; Reyes, Sebastian C. / Effect of oxygen limitations on monoclonal antibody production by immobilized hybridoma cells. In: Biotechnology Progress. 1997 ; Vol. 13, No. 3. pp. 301-310.
@article{dd49e4db3d2441ac81e47da478219c0d,
title = "Effect of oxygen limitations on monoclonal antibody production by immobilized hybridoma cells",
abstract = "The productivity of an immobilized cell biocatalyst is often limited by the amount of oxygen that reaches cells located at interior regions of the biocatalyst. These diffusive limitations depend on a multitude of factors including the oxygen supply, the cellular uptake kinetics, and the cell density of the material. Large cell densities, which are desired for high productivity, are also likely to reduce the percentage of cells that receive an adequate supply of oxygen. To develop a better understanding of how different conditions affect biocatalyst behavior, a computational model of immobilized hybridoma cells was developed. The model accounts for oxygen diffusion and consumption, cell proliferation and death, and monoclonal antibody production. This model assumes that cellular productivity is limited only by the supply of oxygen and that the growth media is continually replenished so that nutrient levels remain high and wastes are eliminated. Biocatalyst performance is evaluated by monitoring the amount of monoclonal antibody produced by the cells. Model predictions agree with experimental measurements reported in the literature and indicate that for long operation time the supply of oxygen, biocatalyst size, and cell kinetics have a significant effect on biocatalyst performance, whereas the initial cell loading has only a relatively small effect. Under typical culture conditions, we find that oxygen penetrates to a maximum depth of about 0.4 mm. Accordingly, cells immobilized farther than this threshold distance receive an insufficient supply of oxygen.",
author = "Mark Riley and Muzzio, {Fernando J.} and Reyes, {Sebastian C.}",
year = "1997",
month = "5",
day = "1",
doi = "10.1021/bp970028n",
language = "English (US)",
volume = "13",
pages = "301--310",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of oxygen limitations on monoclonal antibody production by immobilized hybridoma cells

AU - Riley, Mark

AU - Muzzio, Fernando J.

AU - Reyes, Sebastian C.

PY - 1997/5/1

Y1 - 1997/5/1

N2 - The productivity of an immobilized cell biocatalyst is often limited by the amount of oxygen that reaches cells located at interior regions of the biocatalyst. These diffusive limitations depend on a multitude of factors including the oxygen supply, the cellular uptake kinetics, and the cell density of the material. Large cell densities, which are desired for high productivity, are also likely to reduce the percentage of cells that receive an adequate supply of oxygen. To develop a better understanding of how different conditions affect biocatalyst behavior, a computational model of immobilized hybridoma cells was developed. The model accounts for oxygen diffusion and consumption, cell proliferation and death, and monoclonal antibody production. This model assumes that cellular productivity is limited only by the supply of oxygen and that the growth media is continually replenished so that nutrient levels remain high and wastes are eliminated. Biocatalyst performance is evaluated by monitoring the amount of monoclonal antibody produced by the cells. Model predictions agree with experimental measurements reported in the literature and indicate that for long operation time the supply of oxygen, biocatalyst size, and cell kinetics have a significant effect on biocatalyst performance, whereas the initial cell loading has only a relatively small effect. Under typical culture conditions, we find that oxygen penetrates to a maximum depth of about 0.4 mm. Accordingly, cells immobilized farther than this threshold distance receive an insufficient supply of oxygen.

AB - The productivity of an immobilized cell biocatalyst is often limited by the amount of oxygen that reaches cells located at interior regions of the biocatalyst. These diffusive limitations depend on a multitude of factors including the oxygen supply, the cellular uptake kinetics, and the cell density of the material. Large cell densities, which are desired for high productivity, are also likely to reduce the percentage of cells that receive an adequate supply of oxygen. To develop a better understanding of how different conditions affect biocatalyst behavior, a computational model of immobilized hybridoma cells was developed. The model accounts for oxygen diffusion and consumption, cell proliferation and death, and monoclonal antibody production. This model assumes that cellular productivity is limited only by the supply of oxygen and that the growth media is continually replenished so that nutrient levels remain high and wastes are eliminated. Biocatalyst performance is evaluated by monitoring the amount of monoclonal antibody produced by the cells. Model predictions agree with experimental measurements reported in the literature and indicate that for long operation time the supply of oxygen, biocatalyst size, and cell kinetics have a significant effect on biocatalyst performance, whereas the initial cell loading has only a relatively small effect. Under typical culture conditions, we find that oxygen penetrates to a maximum depth of about 0.4 mm. Accordingly, cells immobilized farther than this threshold distance receive an insufficient supply of oxygen.

UR - http://www.scopus.com/inward/record.url?scp=0031148805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031148805&partnerID=8YFLogxK

U2 - 10.1021/bp970028n

DO - 10.1021/bp970028n

M3 - Article

VL - 13

SP - 301

EP - 310

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 3

ER -